Germany challenges AstraZeneca Covid vaccine efficacy reports
by Philip Oltermann in Berlin from Science | The Guardian on (#5DAQF)
Report said ministers expected EU regulator's assessment to show jab was only 8% effective among over-65s
The German government has challenged reports of a lower-than-expected efficacy rate of the Oxford/AstraZeneca vaccine for older people, while reiterating concerns about the British-Swedish pharmaceutical giant's data reporting.
An article in German business daily Handelsblatt had reported that the German government was expecting the European Medicines Agency's (EMA) assessment to show the AstraZeneca vaccine to be only 8% effective among the over-65s, describing it a setback for Berlin's vaccination strategy".
Continue reading...